Published in Oral Surg Oral Med Oral Pathol Oral Radiol Endod on March 25, 2010
Fibro-osseous lesions of the craniofacial skeleton: an update. Head Neck Pathol (2014) 1.02
Fibro-osseous lesions of the maxillofacial bones. Head Neck Pathol (2013) 0.90
Quantitative analysis of activating alpha subunit of the G protein (Gsα) mutation by pyrosequencing in fibrous dysplasia and other bone lesions. J Mol Diagn (2011) 0.82
Gnathodiaphyseal dysplasia: report of a family with a novel mutation of the ANO5 gene. Oral Surg Oral Med Oral Pathol Oral Radiol (2016) 0.76
Diagnosing the most common odontogenic cystic and osseous lesions of the jaws for the practicing pathologist. Mod Pathol (2017) 0.75
Autosomal dominant mesomandibular fibro-osseous dysplasia: a self-resolving inherited fibro-osseous lesion of the jaws. Front Physiol (2012) 0.75
Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med (1991) 7.17
Fibrous dysplasia. Pathophysiology, evaluation, and treatment. J Bone Joint Surg Am (2005) 3.44
Fibro-osseous lesions of the jaws. J Oral Maxillofac Surg (1993) 3.28
HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet (2002) 3.07
Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am J Pathol (1994) 2.86
Fibrous dysplasia and cemento-ossifying fibroma. A histologic spectrum. Am J Surg Pathol (1995) 1.98
Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone. J Bone Miner Res (2000) 1.65
Medical therapy in adults with fibrous dysplasia of bone. J Bone Miner Res (2006) 1.50
Ossifying fibroma vs fibrous dysplasia of the jaw: molecular and immunological characterization. Mod Pathol (2007) 1.49
Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations. J Clin Endocrinol Metab (2003) 1.36
G(s)alpha mutations in fibrous dysplasia and McCune-Albright syndrome. J Bone Miner Res (2006) 1.36
Lesions of the jaws. Histopathology (2008) 1.33
Onset, progression, and plateau of skeletal lesions in fibrous dysplasia and the relationship to functional outcome. J Bone Miner Res (2007) 1.22
An unusual presentation of McCune-Albright syndrome confirmed by an activating mutation of the Gs alpha-subunit from a bone lesion. J Clin Endocrinol Metab (1994) 1.12
Gnathodiaphyseal dysplasia: a syndrome of fibro-osseous lesions of jawbones, bone fragility, and long bone bowing. J Bone Miner Res (2001) 1.06
The hyperparathyroidism-jaw tumour syndrome in a Portuguese kindred. QJM (2001) 0.99
Juvenile psammomatoid ossifying fibroma of the neurocranium. Report of four cases. J Neurosurg (2005) 0.98
A novel technique based on a PNA hybridization probe and FRET principle for quantification of mutant genotype in fibrous dysplasia/McCune-Albright syndrome. Nucleic Acids Res (2004) 0.93
Calcified spherules in fibro-osseous lesions of bone. Arch Pathol Lab Med (1993) 0.85
Fibrous dysplasia associated with primary hyperparathyroidism in the absence of the McCune-Albright syndrome: Tc-99m MIBI and Tc-99m MDP findings. Clin Nucl Med (2003) 0.81
Craniofacial fibrous dysplasia associated with primary hyperparathyroidism. Acta Biomed Ateneo Parmense (1999) 0.80
EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol (2008) 5.46
Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol (2008) 3.55
(-)-gossypol inhibits growth and promotes apoptosis of human head and neck squamous cell carcinoma in vivo. Neoplasia (2006) 1.55
Quantitative analysis of syndecan-1 expression in dysplasia and squamous cell carcinoma of the oral cavity. Laryngoscope (2007) 1.48
High-throughput multiplexed T-cell-receptor excision circle quantitative PCR assay with internal controls for detection of severe combined immunodeficiency in population-based newborn screening. Clin Chem (2010) 1.38
Rap1GAP promotes invasion via induction of matrix metalloproteinase 9 secretion, which is associated with poor survival in low N-stage squamous cell carcinoma. Cancer Res (2008) 1.35
Identification of a putative tumor suppressor gene Rap1GAP in pancreatic cancer. Cancer Res (2006) 1.34
Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer. Cancer (2010) 1.32
Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smoking. Int J Radiat Oncol Biol Phys (2007) 1.31
Rap1GAP inhibits tumor growth in oropharyngeal squamous cell carcinoma. Am J Pathol (2006) 1.26
Rap1A and rap1B ras-family proteins are prominently expressed in the nucleus of squamous carcinomas: nuclear translocation of GTP-bound active form. Oncogene (2003) 1.22
Invasiveness as a barrier to self-monitoring of blood glucose in diabetes. Diabetes Technol Ther (2005) 1.21
Cone-beam computed tomography to detect erosions of the temporomandibular joint: Effect of field of view and voxel size on diagnostic efficacy and effective dose. Am J Orthod Dentofacial Orthop (2011) 1.21
Impact of the mitogen-activated protein kinase pathway on parathyroid hormone-related protein actions in osteoblasts. J Biol Chem (2004) 1.16
Tristetraprolin regulates interleukin-6, which is correlated with tumor progression in patients with head and neck squamous cell carcinoma. Cancer (2011) 1.12
Bone quality evaluation: comparison of cone beam computed tomography and subjective surgical assessment. Int J Oral Maxillofac Implants (2012) 1.08
Tristetraprolin regulates interleukin-6 expression through p38 MAPK-dependent affinity changes with mRNA 3' untranslated region. J Interferon Cytokine Res (2011) 1.07
Rap1 stabilizes beta-catenin and enhances beta-catenin-dependent transcription and invasion in squamous cell carcinoma of the head and neck. Clin Cancer Res (2009) 1.07
A p38alpha selective mitogen-activated protein kinase inhibitor prevents periodontal bone loss. J Pharmacol Exp Ther (2006) 1.04
Targeting mRNA stability arrests inflammatory bone loss. Mol Ther (2008) 1.04
Molecular pathogenesis of primary hyperparathyroidism. J Bone Miner Res (2002) 1.02
Inactivation or loss of TTP promotes invasion in head and neck cancer via transcript stabilization and secretion of MMP9, MMP2, and IL-6. Clin Cancer Res (2013) 0.98
Galanin receptor 1 has anti-proliferative effects in oral squamous cell carcinoma. J Biol Chem (2005) 0.94
High SEPT9_v1 Expression Is Associated with Poor Clinical Outcomes in Head and Neck Squamous Cell Carcinoma. Transl Oncol (2010) 0.92
The Histone Methyltransferase EZH2 Mediates Tumor Progression on the Chick Chorioallantoic Membrane Assay, a Novel Model of Head and Neck Squamous Cell Carcinoma. Transl Oncol (2013) 0.92
Adenovirus encoding human platelet-derived growth factor-B delivered to alveolar bone defects exhibits safety and biodistribution profiles favorable for clinical use. Hum Gene Ther (2009) 0.92
Performance of elastography for the evaluation of thyroid nodules: a prospective study. Thyroid (2013) 0.92
Cyclin D1 overexpression increases susceptibility to 4-nitroquinoline-1-oxide-induced dysplasia and neoplasia in murine squamous oral epithelium. Mol Carcinog (2009) 0.91
Fungiform papilla pattern: EGF regulates inter-papilla lingual epithelium and decreases papilla number by means of PI3K/Akt, MEK/ERK, and p38 MAPK signaling. Dev Dyn (2008) 0.90
Tyrosine kinase inhibitor, genistein, reduces renal inflammation and injury in streptozotocin-induced diabetic mice. Vascul Pharmacol (2011) 0.90
Rap1 mediates galanin receptor 2-induced proliferation and survival in squamous cell carcinoma. Cell Signal (2011) 0.89
Reciprocal relation between GADD153 and Del-1 in regulation of salivary gland inflammation in Sjögren syndrome. Exp Mol Pathol (2013) 0.89
Stromal-derived factor-1alpha (CXCL12) levels increase in periodontal disease. J Periodontol (2008) 0.88
High matrix metalloproteinase activity is a hallmark of periapical granulomas. J Endod (2009) 0.88
Higher micronutrient intake is associated with human papillomavirus-positive head and neck cancer: a case-only analysis. Nutr Cancer (2011) 0.88
Effects of chromium picolinate on glycemic control and kidney of the obese Zucker rat. Nutr Metab (Lond) (2009) 0.87
Influence of anatomical location on CT numbers in cone beam computed tomography. Oral Surg Oral Med Oral Pathol Oral Radiol (2013) 0.87
Renal and glycemic effects of high-dose chromium picolinate in db/db mice: assessment of DNA damage. J Nutr Biochem (2011) 0.86
Pituitary adenoma with paraganglioma/pheochromocytoma (3PAs) and succinate dehydrogenase defects in humans and mice. J Clin Endocrinol Metab (2015) 0.85
Oral manifestations of internal malignancy and paraneoplastic syndromes. Dent Clin North Am (2008) 0.84
Adenomatoid odontogenic tumor developing in association with an odontoma: report of a case. Quintessence Int (2008) 0.83
Inflammatory cytokines as predictive markers for early detection and progression of diabetic nephropathy. EPMA J (2010) 0.83
The G protein-coupled receptor GALR2 promotes angiogenesis in head and neck cancer. Mol Cancer Ther (2014) 0.82
Differential expression of mitogen activating protein kinases in periodontitis. J Clin Periodontol (2013) 0.81
Cyclin D1 and cyclin D-dependent kinases enhance oral keratinocyte proliferation but do not block keratinocyte differentiation. Int J Oncol (2010) 0.81
The CS1 segment of fibronectin is involved in human OSCC pathogenesis by mediating OSCC cell spreading, migration, and invasion. BMC Cancer (2010) 0.81
Rap1 and its regulatory proteins: the tumor suppressor, oncogene, tumor suppressor gene axis in head and neck cancer. Small GTPases (2012) 0.81
Renal distal tubule proliferation and increased aquaporin 2 level but decreased urine osmolality in db/db mouse: treatment with chromium picolinate. Exp Mol Pathol (2011) 0.80
cAMP binding protein assay for widespread use in cell signaling studies. Biotechniques (2002) 0.79
Oral squamous carcinoma cells secrete RANKL directly supporting osteolytic bone loss. Oral Oncol (2012) 0.79
Characterization of squamous cell carcinoma in an organotypic culture via subsurface non-linear optical molecular imaging. Exp Biol Med (Maywood) (2013) 0.79
Submandibular gland and caries susceptibility in the obese Zucker rat. J Oral Pathol Med (2010) 0.79
Evaluation of the Upper Airway Morphology: The Role of Cone Beam Computed Tomography. J Calif Dent Assoc (2015) 0.78
Characterization of an optically stimulated dosimeter for dentomaxillofacial dosimetry. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2011) 0.78
Differential effects of taurine treatment and taurine deficiency on the outcome of renal ischemia reperfusion injury. J Biomed Sci (2010) 0.78
Periodontitis associated with Chediak-Higashi syndrome in a young African American male. J Int Acad Periodontol (2010) 0.78
Recovery of salivary epidermal growth factor in parotid saliva following parotid sparing radiation therapy: a proof-of-principle study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2011) 0.77
Effects of dietary salt and fat on taurine excretion in healthy and diseased rats. Adv Exp Med Biol (2006) 0.77
Implant compression necrosis: current understanding and case report. J Periodontol (2009) 0.77
Personalized medicine for cancer therapy: Lessons learned from tumor-associated antigens. Oncoimmunology (2013) 0.76
Radioguided tumorectomy in the management of parathyroid adenomas. Arch Surg (2003) 0.76
Clinical-pathological conference: case 5. Head Neck Pathol (2010) 0.75
Gingival lesions in a 21-year-old man. J Am Dent Assoc (2012) 0.75
Fine needle aspiration findings in malignant ameloblastoma: a case report and differential diagnosis. Diagn Cytopathol (2009) 0.75
Trends in Dentomaxillofacial Imaging. J Calif Dent Assoc (2015) 0.75
Corrigendum: TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer. Nat Commun (2016) 0.75
Mucous membrane pemphigoid: a retrospective study. J Mich Dent Assoc (2007) 0.75
Evidence and Professional Guidelines for Appropriate Use of Cone Beam Computed Tomography. J Calif Dent Assoc (2015) 0.75
Intracerebral hemorrhage with hypothyroidism. J Stroke Cerebrovasc Dis (2013) 0.75